Savaria (TSE:SIS) Director Sells C$450,515.52 in Stock

Savaria Co. (TSE:SIS) Director Jean-Louis Chapdelaine sold 14,898 shares of Savaria stock in a transaction dated Friday, August 7th. The stock was sold at an average price of C$30.24, for a total value of C$450,515.52. Following the sale, the director directly owned 100,000 shares of the company’s stock, valued at approximately C$3,024,000. This represents a 12.97% decrease in their position.

Jean-Louis Chapdelaine also recently made the following trade(s):

• On Friday, August 7th, Jean-Louis Chapdelaine sold 10,917 shares of Savaria stock. The shares were sold at an average price of C$30.24, for a total value of C$330,130.08.
• On Friday, August 7th, Jean-Louis Chapdelaine sold 13,020 shares of Savaria stock. The shares were sold at an average price of C$30.24, for a total value of C$393,724.80.
• On Friday, August 7th, Jean-Louis Chapdelaine sold 10,053 shares of Savaria stock. The stock was sold at an average price of C$30.24, for a total value of C$304,002.72.
• On Friday, August 7th, Jean-Louis Chapdelaine sold 10,623 shares of Savaria stock. The stock was sold at an average price of C$30.24, for a total value of C$321,239.52.
• On Tuesday, May 12th, Jean-Louis Chapdelaine sold 25,000 shares of Savaria stock. The stock was sold at an average price of C$27.73, for a total value of C$693,250.00.

Savaria Stock Performance

TSE SIS traded down C$0.44 during trading hours on Friday, reaching C$30.40. The stock had a trading volume of 354,038 shares, compared to its average volume of 180,113. Savaria Co. has a 52-week low of C$20.10 and a 52-week high of C$31.95. The stock has a fifty day moving average of C$29.77 and a 200 day moving average of C$27.84. The company has a debt-to-equity ratio of 31.42, a quick ratio of 0.91 and a current ratio of 1.71. The stock has a market cap of C$2.19 billion, a P/E ratio of 27.64, a price-to-earnings-growth ratio of 42.72 and a beta of 1.04.

Savaria (TSE:SIS) last posted its quarterly earnings results on Wednesday, August 5th. The company reported C$0.35 earnings per share (EPS) for the quarter. Savaria had a net margin of 8.50% and a return on equity of 12.41%. The company had revenue of C$245.78 million during the quarter. Sell-side analysts predict that Savaria Co. will post 1.2048518 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on SIS shares. TD Securities raised shares of Savaria to a “strong-buy” rating in a report on Friday, July 24th. Desjardins upped their price target on shares of Savaria from C$36.00 to C$39.00 and gave the company a “buy” rating in a report on Friday. TD upped their price target on shares of Savaria from C$35.00 to C$37.00 and gave the company a “buy” rating in a report on Friday. ATB Cormark Capital Markets increased their price target on Savaria from C$35.00 to C$38.00 and gave the stock an “outperform” rating in a research report on Friday. Finally, Scotia lifted their price objective on Savaria from C$30.00 to C$33.00 and gave the company a “sector outperform” rating in a research note on Thursday, April 16th. One equities research analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of C$34.33.

About Savaria

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.